Extended Bisphosphonate Treatment Does Not Improve Survival in High-Risk Early Breast Cancer
There was no benefit to extending zoledronate treatment beyond 2 years.
Ob/Gyn Information Center
FDA Requests Removal of Pregnancy Contraindication for Statins
The FDA conducted a comprehensive review of all available data associated with the use of statins during pregnancy.
Disparities in Breast Cancer Survival Persist for Black Women
Although nearly all metrics improved for racial-ethnic minorities, recent breast cancer-related mortality in Florida still higher in Black women
Oral Contraceptives Lower Ovarian Cancer Risk in BRCA Carriers
Findings seen in BRCA1 and BRCA2 mutation carriers; reduction greater with longer duration of use in BRCA1 carriers
Gestational Diabetes May Increase Risk for Fetal Hypoxia
Hypoxia-related ZigZag pattern, late decelerations of FHR on intrapartal CTG and increased risk of fetal asphyxia seen in GDM pregnancies
Prenatal Exposure to Ultrafine Particles Tied to Childhood Asthma
The cumulative odds ratio for incident asthma in children was 4.28 per doubling of UFP exposure level across pregnancy.
Preeclampsia May Be a Risk Factor for Later-Life Stroke
A team of investigators conducted a population-based cohort study to determine whether preeclampsia history affected the relative risk for incident stroke.
Lumbar Spine BMD Predictive of Fracture Among Women Transitioning to Menopause
The SWAN study assessed associations between demographic and clinical characteristics with risk of fracture in premenopausal and postmenopausal women.
Tenofovir Disoproxil Fumarate Shows Long-Term Safety in Infants
Investigators analyzed the safety of tenofovir disoproxil fumarate therapy during the third trimester of pregnancy.
Brexafemme Approved for Vulvovaginal Candidasis
The approval was based on data from 2phase 3 trials that compared Brexafemme to placebo in patients aged 12 years and older with acute VVC.
Immediate Kangaroo Mother Care Aids Low-Birth-Weight Infants
Reduced 28-day mortality seen for infants with birth weight of 1.0 to 1.799 kg who received immediate versus delayed kangaroo mother care
Abaloparatide Linked to Lower Fracture Risk in Women With Osteoporosis, Obesity
A post hoc analysis of the phase 3 ACTIVE trial of abaloparatide for fracture prevention in postmenopausal women was presented at ENVISION, the 2021 AACE Annual Meeting.
Impact of SARS-CoV-2 on Pregnancy Outcomes in Black Persons
What we can learn from the 2020 pandemic’s effect on non-Hispanic pregnant Black persons infected with COVID-19 who are already at heighten risk for morbidity and mortality during pregnancy.
HPV Self-Screening Is Effective in Rural Communities
At-home HPV self-sampling may be a viable option to increase cervical screening rates in rural, underserved women.
5 Lifestyle Changes That May Help Overactive Bladder Symptoms
Patients with overactive bladders may experience stress, embarrassment, and a lowered quality of life. However, there are a number of lifestyle changes they can implement that may lessen their symptoms. Making some small changes can be easier than patients realize. What are some changes patients can make?
Pertussis Vaccination in Pregnancy Not Linked to Asthma, Infections in Children
Tdap exposure is linked to a reduced risk for upper respiratory, gastrointestinal infections in children up to 6 years of age.
Increased Risk for Mortality Due to Pregnancy-Associated Stroke in Black Women
At the 2021 International Stroke Conference, study researchers presented their findings regarding racial disparities in mortality due to pregnancy associated stroke.
Model May Predict Postpartum Hemorrhage With Immune Thrombocytopenia
Researchers attempted to develop a predictive model for the risk of postpartum hemorrhage in patients who have ITP.
Effects of Treatment, Inactivity on Arm Tissue Composition in Survivors of Breast Cancer
Results of an assessment of tissue composition changes experienced by breast cancer survivors without lymphedema are presented.
Does Epilepsy Medication Use in Pregnancy Affect Child’s Neurodevelopment?
Lamotrigine and/or levetiracetam taken during pregnancy were not linked to development delays in children at 3 years.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Ob/Gyn Information Center
Loading... 
Loading...